accountdesign versus older drug-eluting stent model NATICK, Mass. and NEW ORLEANS, April 3, 2011 /PRNewswire via COMTEX/ -- Boston Scientific Corporation /quotes/comstock/13*!bsx/quotes/nls/bsx (BSX 7.30, +0.11, +1.53%) today announced results from a pooled...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Boston Scientific ION(TM) Platinum Chromium Stent System Demonstrates Strong Performance in Analysis of PERSEUS and TAXUS ATLAS Clinical Trial Data
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account